請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/79017
標題: | 利用羧酸甜菜鹼兩性離子聚合物修飾非磷脂質之高固醇載體包覆艾黴素應用於癌細胞治療 Development of Poly(carboxybetaine) Modified Non-phospholipid Sterosomes as Doxorubicin Carrier for Cancer Therapy |
作者: | Shuo-Hsiang Chou 周碩祥 |
指導教授: | 蔡偉博(Wei-Bor Tsai) |
關鍵字: | 抗腫瘤治療,非磷脂載體,脂質體,艾黴素,葉酸,羥基甜菜鹼聚合物, cancer treatment,sterosomes,doxorubicin,folic acid,poly(carboxybetaine), |
出版年 : | 2020 |
學位: | 碩士 |
摘要: | 聚乙二醇修飾之脂質體已經廣泛被用來作為藥物載體應用於癌細胞治療。然而,高成本的磷脂質與其在血液中的不穩定性和聚乙二醇修飾所衍生的問題限制了其應用的範疇。藉此,我們提出一個由棕梠酸和高含量膽固醇組成的非磷脂質藥物載體,藉由羥基甜菜鹼超親水性聚合物長度和重量百分比最佳化的表面修飾條件之後,由於羥基甜菜鹼超親水性聚合物良好的抗蛋白質吸附能力,體外結果顯示有效提升在蛋白質溶液中的穩定性,進而能夠躲避巨噬細胞的辨識達到延長載體在血液中的循環時間。 進而乃至於癌細胞的治療應用,我們嘗試在修飾載體表面之高分子羥基甜菜鹼超親水性聚合物接枝上具有標靶功能可被細胞辨識的葉酸分子,包覆艾黴素作為海拉癌細胞的體外治療。從體外的毒殺試驗中,結果顯示接枝上葉酸的羥基甜菜鹼修飾高固醇載體相較羥基甜菜鹼修飾的高固醇載體具有比較好的細胞毒殺效果,而羥基甜菜鹼修飾特性也使其比相較單純施以艾黴素更能減少對一般細胞的毒性,在能不被免疫系統辨識的修飾條件下,增加藥物積累於腫瘤細胞,提升對腫瘤細胞的選擇率,此結果也與體外細胞攝取的試驗結果相呼應。藉由這些體外試驗的研究結果,顯示此由葉酸接枝的羥基甜菜鹼修飾高固醇載體具有良好乘載抗癌小分子藥物做為癌症治療的潛力。 Over the past few decades, liposomes composed of phospholipids have been emerging as a useful mean for drug delivery. However, the expensiveness of phospholipids and unstableness of phospholipid liposomes in the blood limit their wide applications. To surmount the challenge, we developed a non-phospholipid sterosomes decorated with a zwitterionic poly(carboxybetaine) (PCB). Superhydrophilic PCB, comparable with PEG, is expected to keep sterosomes more stable in complex media such as blood, and to imbue them with the stealth properties for escaping MPS clearance, prolonging the circulation time. In addition, targeting ligands of folic acid was conjugated to PCB-modified sterosomes, and doxorubicin was incorporated into the sterosomes for anti-cancer treatment. The results of cellular uptake indicated that the folic acid conjugated PCB-modified sterosomes triggered less the activation of macrophages and enhancement in HeLa cancer cells owing to FA decoration. Also, the results of cytotoxicity efficiency showed the decrement of HeLa in cell viability, reducing systemic toxicity of L929 fibroblast cells. All the results in vitro study mention above contributed to better selectivity of tumor cells compared to pure doxorubicin treatment, suggesting that this folic acid decorated PCB-modified sterosomes are more suitable as drug delivery carriers for anti-tumor therapy in conclusion. |
URI: | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/79017 |
DOI: | 10.6342/NTU202003915 |
全文授權: | 有償授權 |
電子全文公開日期: | 2023-08-18 |
顯示於系所單位: | 化學工程學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
U0001-1808202003454200.pdf 目前未授權公開取用 | 5.63 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。